北京
分享至
11月6日，CDE网站显示，艾伯维(ABBV.US)的CD3/CD20双抗艾可瑞妥单抗(epcoritamab，美国商品名：Epkinly)在中国申报上市。
本文源自：金融界AI电报
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
